skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Telomerase: 540-548 Peptide Vaccine (Code C2640)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Telomerase: 540-548 Peptide Vaccine

Definition: A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells. (NCI04)

Label: Telomerase: 540-548 Peptide Vaccine

NCI Thesaurus Code: C2640 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0935896  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Telomerase: 540-548 Peptide Vaccine
Telomerase:540-548 Peptide

External Source Codes: 
NSC Code 720002 (see NCI DTP info)
PDQ Closed Trial Search ID 38362
PDQ Open Trial Search ID 38362 (check for NCI PDQ open clinical trial info)
UMLS CUI C0935896

Other Properties:
     Name Value (qualifiers indented underneath)
code C2640
Legacy_Concept_Name Telomerase_540-548_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom